OCM
EBS icon

Orion Capital Management’s Emergent Biosolutions EBS Stock Holding History

Orion Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,900
Closed -$126K – 412
2021
Q4 		$126K Sell
2,900
-800
-22% -$36.2K 0.07% 150
2021
Q3 		$185K Sell
3,700
-900
-20% -$54.5K 0.11% 117
2021
Q2 		$290K Hold
4,600
– – 0.18% 89
2021
Q1 		$427K Hold
4,600
– – 0.3% 73
2020
Q4 		$412K Buy
+4,600
New +$422K 0.3% 66

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Orion Capital Management's EBS Position: Q1 2022 in Review

Orion Capital Management sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 2,900 shares — an estimated $126K sold.

Orion Capital Management first reported a position in EBS in Q4 2020 and held it in 5 quarters. The position peaked at $427K in Q1 2021. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

  • Orion Capital Management reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
  • Orion Capital Management sold 2,900 Emergent Biosolutions shares in Q1 2022, an estimated $126K.
  • Orion Capital Management first reported a position in Emergent Biosolutions in Q4 2020 and held it in 5 quarters.
  • Orion Capital Management's Emergent Biosolutions position peaked at $427K in Q1 2021.
  • 255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Orion Capital Management's 13F filing for Q1 2022, filed 11 May 2022.